We are thrilled to announce that Dr. Panos Zanos, the Principal Investigator of the Translational Neuropharmacology Lab, has been appointed as a member of the Cyprus National Bioethics Committee (CNBC) following a rigorous application and interview process. The CNBC plays a pivotal role in advising and guiding ethical practices in research, healthcare, and policy-making in […]

Read More »

We are excited to share that Stylianos Valiantis, a talented Ph.D. student in the Translational Neuropharmacology Lab, has been awarded a fellowship to support their doctoral training! This highly competitive award, granted based on academic merit and research potential, highlights our Ph.D. students’ potential to advancing neuroscience research. Their work focuses on uncovering novel mechanisms […]

Read More »

We are excited to announce that Dr. Andrea Georgiou, our esteemed Marie-Curie Fellow at the Zanos Lab, has secured her first grant as Principal Investigator! The Research and Innovation Foundation in Cyprus has awarded Dr. Georgiou a prestigious €150,000 grant to advance her innovative research program. Dr. Georgiou’s funded project focuses on unraveling the molecular […]

Read More »

We are thrilled to announce that the Translational Neuropharmacology Lab (Zanos Lab) has been awarded €100,000 in state funds to support our cutting-edge research. These funds will be used to upgrade our laboratory equipment and ensure a steady supply of essential consumables, enabling us to advance our mission of understanding and developing novel therapies for […]

Read More »

We are excited to announce that Dr. Onisiforou from our lab is currently participating in IDWeek 2024, taking place in Los Angeles, USA. IDWeek is a premier international conference bringing together researchers and clinicians to discuss the latest advancements in infectious diseases. At the conference, Dr. Onisiforou is presenting her novel research on the molecular […]

Read More »

We are pleased to share that Dr. Zanos and Dr. Onisiforou from our lab recently participated in the Science of Alzheimer’s & Infectious Diseases Symposium, hosted by the IDSA Foundation. The symposium focused on the emerging connections between infectious diseases and Alzheimer’s disease (AD), bringing together leading experts to discuss the latest scientific advancements in […]

Read More »

We are excited to announce that Dr. Polymnia Louka, our new postdoctoral researcher, has successfully secured €150,000 in funding through the European Marie-Curie Co-Fund. The grant will support her research project titled “Identifying the Effects of Ketamine and Its Metabolites on Depression-Induced Impairment in Bone Health.” Dr. Louka’s project aims to address a critical gap […]

Read More »

We are excited to announce the publication of our latest research in the Computational & Structural Biotechnology Journal, titled “One Path, Two Solutions: Network-Based Analysis Identifies Targetable Pathways for the Treatment of Comorbid Type II Diabetes and Neuropsychiatric Disorders.” This study introduces a novel computational algorithm that provides unprecedented insight into the shared molecular mechanisms […]

Read More »

We are thrilled to announce that the Zanos Lab has been awarded a grant to investigate the cellular and molecular mechanisms behind the antidepressant actions of (2R,6R)-hydroxynorketamine ((2R,6R)-HNK), in collaboration with Prof. Kobi Rosenblum. This metabolite of ketamine has shown promise in inducing rapid antidepressant effects without the adverse effects associated with ketamine itself in […]

Read More »

We are excited to announce that Dr. Zanos recently presented at the prestigious mGlu 2024 meeting in Sicily, Italy. His talk, titled “Interplay between the mGluR2 signalling and ketamine’s rapid antidepressant actions: Exploring the possible role of NMDAR activation,” offered key insights into the mechanisms underlying ketamine’s antidepressant effects. Stay tuned for more research updates […]

Read More »